Skip to content
No results
  • Home
  • News
  • Press Releases
  • Business
  • Technology
  • Research
  • Regulatory
  • Events and Conferences
  • About Us
  • Contact Us
  • About Us
  • Contact Us
The Pharma Data
  • News
  • Press Releases
  • Business
  • Technology
  • Research
  • Regulatory
  • Events and Conferences
The Pharma Data
  • Regulatory

ImmunoScape Names Peter Olagunju as CEO

  • The Pharma Data
  • September 24, 2026

ImmunoScape Appoints Peter Olagunju as CEO to Advance TCR-Based Cancer Immunotherapy Platform Toward the Clinic ImmunoScape Pte. Ltd., an A*STAR spin-out backed by Amgen Ventures and EDBI, has appointed Peter…

Read MoreImmunoScape Names Peter Olagunju as CEO
  • Press Releases

StandardX Raises £10M to Advance Rare Isotope Production for Medicine and Fusion

  • The Pharma Data
  • September 24, 2026

StandardX Raises £10 Million to Build Scalable Isotope Refinery for Medicine and Fusion Energy StandardX, a UK-headquartered European deep technology company founded in 2025, has raised £10 million in seed…

Read MoreStandardX Raises £10M to Advance Rare Isotope Production for Medicine and Fusion
  • Business

Autobahn Reports AMPLIFY-BD Results for Elunetirom in Bipolar Depression

  • The Pharma Data
  • September 22, 2026

Autobahn Therapeutics Reports Positive Phase 2 AMPLIFY-BD Results for Elunetirom in Bipolar Depression Autobahn Therapeutics, Inc., a biotechnology company developing restorative treatments for people living with neuropsychiatric disorders, announced the…

Read MoreAutobahn Reports AMPLIFY-BD Results for Elunetirom in Bipolar Depression
  • News

GreenMan’s InSightVR Study Shows Improved Cataract Patient Understanding and IOL Selection

  • The Pharma Data
  • September 22, 2026

GreenMan Vision Study Finds Virtual Reality May Improve Cataract IOL Education and Patient Satisfaction GreenMan Vision, Inc. has announced the publication of a peer-reviewed, multi-center study evaluating InSightVR, a patient-specific…

Read MoreGreenMan’s InSightVR Study Shows Improved Cataract Patient Understanding and IOL Selection
  • Industry Updates

Pattern Bioscience Receives FDA Breakthrough Device Designation for Urine ID/AST Panel

  • The Pharma Data
  • September 22, 2026

Pattern Bioscience Receives FDA Breakthrough Device Designation for Urine ID/AST Panel Pattern Bioscience, a company developing rapid diagnostic technologies for bacterial infections, has announced that the U.S. Food and Drug…

Read MorePattern Bioscience Receives FDA Breakthrough Device Designation for Urine ID/AST Panel
  • Research

Establishment Labs Highlights Breast Tissue Preservation Data and New Minimally Invasive Products

  • The Pharma Data
  • September 22, 2026

Establishment Labs Presents New Breast Tissue Preservation Data and Expands Minimally Invasive Platform at WSEI Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company focused on advancing women’s…

Read MoreEstablishment Labs Highlights Breast Tissue Preservation Data and New Minimally Invasive Products
  • News

Therapy Becomes the Default Response to Everyday Stress as Employers Expand Coverage

  • The Pharma Data
  • September 22, 2026

Therapy Gains Ground as a Go-To Solution for Everyday Stress and Social Connection Modern Health, a global workplace mental health platform, has released new international research examining how employees use…

Read MoreTherapy Becomes the Default Response to Everyday Stress as Employers Expand Coverage
  • NewsResearch

Alkermes Reports Positive Phase 1b Results for ALKS 7290 in ADHD

  • The Pharma Data
  • September 22, 2026

Alkermes Reports Positive Phase 1 Results for Investigational Orexin 2 Receptor Agonist ALKS 7290 in Adult ADHD Alkermes plc (Nasdaq: ALKS) has announced positive topline results from a Phase 1…

Read MoreAlkermes Reports Positive Phase 1b Results for ALKS 7290 in ADHD
  • Research

Iambic Launches Enchant v3 to Advance End-to-End Drug Discovery and Development

  • The Pharma Data
  • September 22, 2026

Iambic Launches Enchant v3 to Advance AI-Driven End-to-End Drug Discovery Iambic, a clinical-stage life science and technology company developing novel medicines through an artificial intelligence-driven platform, has unveiled Enchant v3,…

Read MoreIambic Launches Enchant v3 to Advance End-to-End Drug Discovery and Development
  • Regulatory

Merck’s KEYTRUDA QLEX Approved in Japan Across All KEYTRUDA Indications

  • The Pharma Data
  • September 22, 2026

Merck’s KEYTRUDA QLEX Approved in Japan for Subcutaneous Use Across KEYTRUDA Indications Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced that Japan’s Ministry of Health,…

Read MoreMerck’s KEYTRUDA QLEX Approved in Japan Across All KEYTRUDA Indications
  • Press Releases

Medincell Partner Teva Presents New Data on Investigational Olanzapine LAI and UZEDY at Psych Congress 2026

  • The Pharma Data
  • September 22, 2026

Medincell Partner Teva Presents New Data on Investigational Olanzapine LAI and UZEDY at Psych Congress 2026 Medincell’s partner Teva Pharmaceuticals presented new clinical and real-world data on two long-acting injectable…

Read MoreMedincell Partner Teva Presents New Data on Investigational Olanzapine LAI and UZEDY at Psych Congress 2026
  • News

Bristol Myers Squibb Reports Durable Efficacy and Consistent Safety With Sotyktu in Psoriatic Arthritis Over Two Years

  • The Pharma Data
  • September 19, 2026

Bristol Myers Squibb Reports Two-Year Data Showing Durable Sotyktu Efficacy in Psoriatic Arthritis Bristol Myers Squibb (NYSE: BMY) announced positive two-year results from the Phase 3 POETYK PsA-2 study and…

Read MoreBristol Myers Squibb Reports Durable Efficacy and Consistent Safety With Sotyktu in Psoriatic Arthritis Over Two Years
PrevNext

About

The Pharma Data is an Information-Centric Website focused mainly on the Pharmaceutical Industry Online It is a B2B Platform mainly focused on the latest Pharmaceutical News, Press releases, Industry-related updates, Events, and Conferences. With The Pharma Data, you can get all the information that happening in the Pharmaceutical industry.

Advertise With Us: marketing@thepharmadata.com

Latest Posts

  • Tenpoint Therapeutics Submits New Drug Application to Health Canada for Adult Presbyopia TreatmentNovember 21, 2026
  • CEL-SCI’s Multikine® Granted Saudi FDA NADR Designation, Advancing Commercialization PlansNovember 21, 2026
  • Fujifilm Enhances ECHELON Synergy 1.5T MRI with ZeroHelium Technology and Dockable Patient TableNovember 21, 2026
  • About Us
  • Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Contact Us

Copyright © 2026 | The Pharma Data | Marnet Technologies Pvt Ltd | All Rights Reserved.